The metabolic dysregulation of cancer cells has been implicated in the development of the immune suppressive TME that inhibits activation of tumour infiltrating cytotoxic CD8+ T cells and natural killer (NK) cells [6]. The gene discussed is CD8A; the disease is neoplasm.